The Food and Drug Administration provides a short window of time of only a few years for an institution to complete a clinical trial. Considering the fact that it is an enormous time consuming and expensive process to obtain subjects for clinical trials, should this time frame be re-assessed to potentially preclude the use of nonconsenting individuals?